Literature DB >> 19047209

The decrease in mature myostatin protein in male skeletal muscle is developmentally regulated by growth hormone.

Jenny M Oldham1, Claire C Osepchook, Ferenc Jeanplong, Shelley J Falconer, Kenneth G Matthews, John V Conaglen, David F Gerrard, Heather K Smith, Richard J Wilkins, James J Bass, Christopher D McMahon.   

Abstract

Myostatin inhibits myogenesis and there is reduced abundance of the mature protein in skeletal muscles of adult male compared with female mice. This reduction probably occurs after translation, which suggests that it is a regulated mechanism to reduce the availability of myostatin in males. Reduced myostatin may, thereby, contribute to the development of sexually dimorphic growth of skeletal muscle. Our first objective was to determine if the decrease in mature myostatin protein occurs before the linear growth phase to aid growth, or afterwards to maintain the mass of adult muscle. Mice were killed from 2 to 32 weeks and the gastrocnemius muscle was excised. Myostatin mRNA increased from 2 to 32 weeks and was higher in males than females (P < 0.001). In contrast, mature protein decreased in males after 6 weeks (P < 0.001). Our second objective was to determine if growth hormone (GH) induces the decrease in mature myostatin protein. GH increased myostatin mRNA and decreased the abundance of mature protein in hypophysectomised mice (P < 0.05). Our final objective was to determine if the decrease in mature protein occurs in skeletal muscles of male Stat5b(-/-) mice (Stat5b mediates the actions of GH). As expected, mature myostatin protein was not reduced in Stat5b(-/-) males compared with females. However, myostatin mRNA remained higher in males than females irrespective of genotype. These data suggest that: (1) the decrease in mature myostatin protein is developmentally regulated, (2) GH acting via Stat5b regulates the abundance of mature myostatin and (3) GH acts via a non-Stat5b pathway to regulate myostatin mRNA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19047209      PMCID: PMC2670088          DOI: 10.1113/jphysiol.2008.161521

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  41 in total

1.  Single and combined effects of growth hormone and testosterone administration on measures of body composition, physical performance, mood, sexual function, bone turnover, and muscle gene expression in healthy older men.

Authors:  Kimberly T Brill; Arthur L Weltman; Angela Gentili; James T Patrie; David A Fryburg; John B Hanks; Randall J Urban; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2002-12       Impact factor: 5.958

2.  Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism.

Authors:  Xiangyang Zhu; Stavros Topouzis; Li-Fang Liang; Ronald L Stotish
Journal:  Cytokine       Date:  2004-06-21       Impact factor: 3.861

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Expression of myostatin pro domain results in muscular transgenic mice.

Authors:  J Yang; T Ratovitski; J P Brady; M B Solomon; K D Wells; R J Wall
Journal:  Mol Reprod Dev       Date:  2001-11       Impact factor: 2.609

5.  Sexual dimorphism is associated with decreased expression of processed myostatin in males.

Authors:  Christopher D McMahon; Ljiljana Popovic; Ferenc Jeanplong; Jenny M Oldham; Sonnie P Kirk; Claire C Osepchook; Karen W Y Wong; Mridula Sharma; Ravi Kambadur; John J Bass
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-10-15       Impact factor: 4.310

6.  STAT5b is required for GH-induced liver IGF-I gene expression.

Authors:  H W Davey; T Xie; M J McLachlan; R J Wilkins; D J Waxman; D R Grattan
Journal:  Endocrinology       Date:  2001-09       Impact factor: 4.736

7.  Temporal relationship between the sexually dimorphic spontaneous GH secretory profiles and hepatic STAT5 activity.

Authors:  G S Tannenbaum; H K Choi; W Gurd; D J Waxman
Journal:  Endocrinology       Date:  2001-11       Impact factor: 4.736

8.  Myostatin is a skeletal muscle target of growth hormone anabolic action.

Authors:  Wei Liu; Scott G Thomas; Sylvia L Asa; Nestor Gonzalez-Cadavid; Shalendar Bhasin; Shereen Ezzat
Journal:  J Clin Endocrinol Metab       Date:  2003-11       Impact factor: 5.958

Review 9.  Human GH pulsatility: an ensemble property regulated by age and gender.

Authors:  J D Veldhuis; C Y Bowers
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

10.  Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin.

Authors:  Suzanne Reisz-Porszasz; Shalender Bhasin; Jorge N Artaza; Ruoqing Shen; Indrani Sinha-Hikim; Aimee Hogue; Thomas J Fielder; Nestor F Gonzalez-Cadavid
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-06-24       Impact factor: 4.310

View more
  16 in total

1.  Insulin signaling and skeletal muscle atrophy and autophagy in transition dairy cows either overfed energy or fed a controlled energy diet prepartum.

Authors:  S Mann; A Abuelo; D V Nydam; F A Leal Yepes; T R Overton; J J Wakshlag
Journal:  J Comp Physiol B       Date:  2016-02-26       Impact factor: 2.200

2.  Age and sex differences in human skeletal muscle fibrosis markers and transforming growth factor-β signaling.

Authors:  Lewan Parker; Marissa K Caldow; Rani Watts; Pazit Levinger; David Cameron-Smith; Itamar Levinger
Journal:  Eur J Appl Physiol       Date:  2017-05-10       Impact factor: 3.078

3.  Endocrine actions of myostatin: systemic regulation of the IGF and IGF binding protein axis.

Authors:  Nolann G Williams; Jillian P Interlichia; Melissa F Jackson; David Hwang; Pinchas Cohen; Buel D Rodgers
Journal:  Endocrinology       Date:  2010-12-08       Impact factor: 4.736

4.  Brief Communication: Sexual dimorphic expression of myostatin and follistatin like-3 in a rat trans-generational under-nutrition model.

Authors:  Hassendrini N Peiris; Anna P Ponnampalam; Murray D Mitchell; Mark P Green
Journal:  Nutr Metab (Lond)       Date:  2010-05-20       Impact factor: 4.169

Review 5.  Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways.

Authors:  J Rodriguez; B Vernus; I Chelh; I Cassar-Malek; J C Gabillard; A Hadj Sassi; I Seiliez; B Picard; A Bonnieu
Journal:  Cell Mol Life Sci       Date:  2014-07-31       Impact factor: 9.261

6.  Identification and expression of a novel transcript of the growth and differentiation factor-11 gene.

Authors:  Ferenc Jeanplong; Shelley J Falconer; Jenny M Oldham; Nauman J Maqbool; Mark Thomas; Alex Hennebry; Christopher D McMahon
Journal:  Mol Cell Biochem       Date:  2013-12-31       Impact factor: 3.396

7.  Targeted loss of GHR signaling in mouse skeletal muscle protects against high-fat diet-induced metabolic deterioration.

Authors:  Archana Vijayakumar; YingJie Wu; Hui Sun; Xiaosong Li; Zuha Jeddy; Chengyu Liu; Gary J Schwartz; Shoshana Yakar; Derek LeRoith
Journal:  Diabetes       Date:  2012-01       Impact factor: 9.461

8.  Discovery of a mammalian splice variant of myostatin that stimulates myogenesis.

Authors:  Ferenc Jeanplong; Shelley J Falconer; Jenny M Oldham; Mark Thomas; Tarra S Gray; Alex Hennebry; Kenneth G Matthews; Frederick C Kemp; Ketan Patel; Carole Berry; Gina Nicholas; Christopher D McMahon
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

9.  Myostatin and beyond in cirrhosis: all roads lead to sarcopenia.

Authors:  Srinivasan Dasarathy
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-12       Impact factor: 12.910

10.  Longissimus dorsi transcriptome analysis of purebred and crossbred Iberian pigs differing in muscle characteristics.

Authors:  Cristina Ovilo; Rita Benítez; Almudena Fernández; Yolanda Núñez; Miriam Ayuso; Ana Isabel Fernández; Carmen Rodríguez; Beatriz Isabel; Ana Isabel Rey; Clemente López-Bote; Luis Silió
Journal:  BMC Genomics       Date:  2014-05-31       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.